Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?
Rev Neurol (Paris)
; 178(3): 266-267, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34579947
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aspergillosis
/
Multiple Sclerosis, Relapsing-Remitting
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Rev Neurol (Paris)
Year:
2022
Document type:
Article
Country of publication: